Ghambaryan Naira, Bollen Curd, Hakobyan Gagik
Department of Oral and Maxillofacial Surgery, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia.
Deptartment Implantology Ulster University, Birmingham, UK.
Oral Maxillofac Surg. 2025 May 13;29(1):100. doi: 10.1007/s10006-025-01395-7.
To evaluate the influence of crown-to-implant ratio(C/I) on marginal bone level changes and survival rate of implants during function.
The study included 68 patients with completely or partial edentulous and severe vertical bone atrophy, which were restored with a single crown(46) or a partial fixed(48) denture supported by 152 short implants. Implants were divided into three groups according to the C/I ratio (1.5:1, 1,75:1, 2:1). The results were evaluated: failures of the implant, any complications, implants marginal bone loss (MBL), implants success rates the follow up for 5 years. MBL was assessed by taking x-rays after restoration fixation, after 1,3,5 years post operatively.
During implantation and in the post-implantation period, no serious biological or prosthetic complications were recorded. After 1 years in Group 1 mean MBL 0.86 ± 0.4 mm, after 3 years 0,98 ± 0.2 mm), after 5 years 1.05 ± 0.3 mm. After 1 years in Group 2 mean MBL 0.97 ± 0.3 mm, after 3 years 1,07 ± 0.4 mm), after 5 years MBL was 1.12 ± 0.6 mm.Аfter 1 years in Group 3 mean MBL 1,08 ± 0.6 mm, after 3 years 1,19 ± 0.2 mm, after 5 years MBL was 1.27 ± 0.3 mm. Short implants cumulative success of implantation after 5 years was 97.8% for group 1, 97.6% for group 2, and 97.3% for group 3. Patients were satisfied with the results of treatment.
The study showed that different C/I ratios of short implants did not affect the survival rate and their use can be considered favorable and completely justified.
Not applicable.
评估冠根比(C/I)对种植体在功能期间边缘骨水平变化及种植体存活率的影响。
该研究纳入68例完全或部分无牙且伴有严重垂直骨吸收的患者,这些患者采用单冠修复(46例)或由152颗短种植体支持的局部固定义齿(48例)修复。根据C/I比(1.5:1、1.75:1、2:1)将种植体分为三组。评估结果包括:种植体失败情况、任何并发症、种植体边缘骨丢失(MBL)、种植体成功率,并进行5年的随访。在修复固定后、术后1年、3年、5年时通过X线片评估MBL。
在种植期间及种植后阶段,未记录到严重的生物学或修复并发症。第1组1年后平均MBL为0.86±0.4mm,3年后为0.98±0.2mm,5年后为1.05±0.3mm。第2组1年后平均MBL为0.97±0.3mm,3年后为1.07±0.4mm,5年后MBL为1.12±0.6mm。第3组1年后平均MBL为1.08±0.6mm,3年后为1.19±0.2mm,5年后MBL为1.27±0.3mm。短种植体5年后的累计种植成功率第1组为97.8%,第2组为97.6%,第3组为97.3%。患者对治疗结果满意。
该研究表明,不同C/I比的短种植体不影响存活率,其使用可被认为是有利且完全合理的。
不适用。